C vs EW · P/E 16, rev $85.22B vs P/E 47, rev $1.39B
Citigroup Inc. (C) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
C currently screens at market cap $214.73B and trailing P/E 15.5. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the C and EW stock pages for the full models.
Not investment advice.